361 related articles for article (PubMed ID: 19433969)
21. Hematopoietic growth factors in acute myeloid leukemia: supportive and priming effects.
Büchner T; Hiddemann W; Wörmann B; Zühlsdorf M; Rottmann R; Innig G; Maschmeier G; Ludwig WD; Sauerland MC; Heinecke A
Semin Oncol; 1997 Feb; 24(1):124-31. PubMed ID: 9045298
[TBL] [Abstract][Full Text] [Related]
22. Phase II trial of subcutaneous recombinant human interleukin 11 with subcutaneous recombinant human granulocyte-macrophage colony stimulating factor in patients with acute myeloid leukemia (AML) receiving high-dose cytarabine during induction: ECOG 3997.
Cripe LD; Rader K; Tallman MS; Gordon MS; Paietta E; Bennett J; Neuberg D; Litzow MR; O'brien TE; Rowe JM
Leuk Res; 2006 Jul; 30(7):823-7. PubMed ID: 16413056
[TBL] [Abstract][Full Text] [Related]
23. Daunorubicin, cytarabine and fludarabine (DAF) for remission induction in relapsed or refractory acute myeloid leukemia. Evaluation of safety, tolerance and early outcome--Polish Adult Leukemia Group (PALG) pilot study.
Hołowiecki J; Grosicki S; Kyrcz-Krzemien S; Skotnicki AB; Piatkowska-Jakubas B; Warzocha K; Seferynska I; Zdziarska B
Ann Hematol; 2008 May; 87(5):361-7. PubMed ID: 18074133
[TBL] [Abstract][Full Text] [Related]
24. Phase II study of combination thalidomide/interleukin-2 therapy plus granulocyte macrophage-colony stimulating factor in patients with metastatic renal cell carcinoma.
Amato RJ; Malya R; Rawat A
Am J Clin Oncol; 2008 Jun; 31(3):237-43. PubMed ID: 18525301
[TBL] [Abstract][Full Text] [Related]
25. Effect of combination therapy with all-trans-retinoic acid and recombinant human granulocyte colony-stimulating factor in patients with myelodysplastic syndromes.
Ganser A; Seipelt G; Verbeek W; Ottmann OG; Maurer A; Kolbe K; Hess U; Elsner S; Reutzel R; Wörmann B
Leukemia; 1994 Mar; 8(3):369-75. PubMed ID: 7510354
[TBL] [Abstract][Full Text] [Related]
26. Granulocyte-macrophage colony-stimulating factor associated with induction treatment of acute myelogenous leukemia: a randomized trial by the European Organization for Research and Treatment of Cancer Leukemia Cooperative Group.
Zittoun R; Suciu S; Mandelli F; de Witte T; Thaler J; Stryckmans P; Hayat M; Peetermans M; Cadiou M; Solbu G; Petti MC; Willemze R
J Clin Oncol; 1996 Jul; 14(7):2150-9. PubMed ID: 8683249
[TBL] [Abstract][Full Text] [Related]
27. Synergistic down-regulation of telomerase activity and hTERT mRNA expression by combination of retinoic acid and GM-CSF in human myeloblastic leukemia ML-1 cells.
Mano Y; Shimizu T; Tanuma S; Takeda K
Anticancer Res; 2000; 20(3A):1649-52. PubMed ID: 10928085
[TBL] [Abstract][Full Text] [Related]
28. The histone deacetylase (HDAC) inhibitor valproic acid as monotherapy or in combination with all-trans retinoic acid in patients with acute myeloid leukemia.
Kuendgen A; Schmid M; Schlenk R; Knipp S; Hildebrandt B; Steidl C; Germing U; Haas R; Dohner H; Gattermann N
Cancer; 2006 Jan; 106(1):112-9. PubMed ID: 16323176
[TBL] [Abstract][Full Text] [Related]
29. [Treatment results in childhood acute myeloblastic leukemia--a report of clinical trials of a past decade from the Japanese children's Cancer and Leukemia Study Group (CCLSG)].
Tsurusawa M; Katano N; Hirota T; Mimaya J; Horikoshi Y; Kawamura N; Yanai M; Kamitamari A; Tsuji Y; Fujimoto T
Rinsho Ketsueki; 1997 Jun; 38(6):505-12. PubMed ID: 9248326
[TBL] [Abstract][Full Text] [Related]
30. Retinoic acid combined with GM-CSF induces morphological changes with segmented nuclei in human myeloblastic leukemia ML-1 cells.
Oka Y; Takeda K
Anticancer Res; 1997; 17(3C):1951-5. PubMed ID: 9216650
[TBL] [Abstract][Full Text] [Related]
31. [Recent progress in the treatment of acute leukemia].
Kimura Y
Gan To Kagaku Ryoho; 2003 Jul; 30(7):895-901. PubMed ID: 12894700
[TBL] [Abstract][Full Text] [Related]
32. Valproic acid and all-trans retinoic acid for the treatment of elderly patients with acute myeloid leukemia.
Raffoux E; Chaibi P; Dombret H; Degos L
Haematologica; 2005 Jul; 90(7):986-8. PubMed ID: 15996941
[TBL] [Abstract][Full Text] [Related]
33. Treatment with all-trans retinoic acid and anthracycline monochemotherapy for children with acute promyelocytic leukemia: a multicenter study by the PETHEMA Group.
Ortega JJ; Madero L; Martín G; Verdeguer A; García P; Parody R; Fuster J; Molines A; Novo A; Debén G; Rodríguez A; Conde E; de la Serna J; Allegue MJ; Capote FJ; González JD; Bolufer P; González M; Sanz MA;
J Clin Oncol; 2005 Oct; 23(30):7632-40. PubMed ID: 16234524
[TBL] [Abstract][Full Text] [Related]
34. [Successful treatment with combination of all-trans retinoic acid (ATRA) and rhG-CSF a relapsed acute promyelocytic leukemia with umbilical tumor].
Abe Y; Takatsuki H; Okada Y; Yufu Y; Kimura T; Nishimura J; Nawata H; Oshima K; Kikuchi M
Rinsho Ketsueki; 1996 Dec; 37(12):1395-9. PubMed ID: 8997128
[TBL] [Abstract][Full Text] [Related]
35. [Combination of interferon-alpha and all-trans-retinoic acid as a treatment for maintaining remission in high-risk group patients with acute myeloid leukemia].
Parovichnikova EN; Savchenko VG; Isaev VG; Demidova IA; Ol'shanskaia IuV; Lapin VA; Cherepanova VV; Rekhtman GB; Perekatova TN
Ter Arkh; 2001; 73(7):15-20. PubMed ID: 11523403
[TBL] [Abstract][Full Text] [Related]
36. [Cost effectiveness of GM-CSF in the treatment of acute myeloblastic leukemia in aged patients: protocol of GOELAM Sa3].
Woronoff-Lemsi MC; Witz F; Arveux P; Cahn JY; Harousseau JL;
Therapie; 2001; 56(2):131-3. PubMed ID: 11471363
[TBL] [Abstract][Full Text] [Related]
37. Effect of low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor priming (CAG regimen) on the outcome of elderly patients with acute myeloid leukemia.
Qian SX; Li JY; Tian T; Shen YF; Jiang YQ; Lu H; Wu HX; Zhang SJ; Xu W
Leuk Res; 2007 Oct; 31(10):1383-8. PubMed ID: 17420048
[TBL] [Abstract][Full Text] [Related]
38. Use of cytokines in the treatment of acute myelocytic leukemia: a critical review.
Geller RB
J Clin Oncol; 1996 Apr; 14(4):1371-82. PubMed ID: 8648396
[TBL] [Abstract][Full Text] [Related]
39. Application of recombinant human granulocyte colony stimulating factor in children with acute myeloid leukemia.
Shang X; Yin H; Lu A; Zhang L
Chin Med J (Engl); 1999 Jul; 112(7):620-2. PubMed ID: 11601256
[TBL] [Abstract][Full Text] [Related]
40. Granulocyte-macrophage colony-stimulating factor (GM-CSF), given concurrently with induction therapy for acute myelogenous leukemia (AML), augments the syndrome of T-lymphocyte recovery.
Gore SD; Donnenberg AD; Zehnbauer BA; Weng LJ; Burke PJ
Leukemia; 1994 Mar; 8(3):409-19. PubMed ID: 8127146
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
